Hormone Replacement Therapy (HRT) is often prescribed to manage menopausal symptoms. Like hormonal contraceptives, HRT containing estrogen can elevate the risk of thromboembolic events. The risk varies depending on the type, route, and duration of HRT. Transdermal estrogen is generally considered to have a lower risk compared to oral estrogen.